We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYV icon
3076
Live Nation Entertainment
LYV
$41.2B
$241K ﹤0.01%
2,913
-106,209
-97% -$10.2M
BHIL.WS
3077
CALL
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$241K ﹤0.01%
88,494
+3,433
+4% +$1.61K
LUNA
3078
DELISTED
Luna Innovations Incorporated
LUNA
$241K ﹤0.01%
41,378
+11,051
+36% +$65.2K
BRBS icon
3079
Blue Ridge Bankshares
BRBS
$311M
$240K ﹤0.01%
15,686
-17,841
-53% -$264K
PRLD icon
3080
Prelude Therapeutics
PRLD
$305M
$238K ﹤0.01%
45,716
-66,061
-59% -$336K
PTR
3081
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$237K ﹤0.01%
5,079
-117,615
-96% -$5.93M
IFS icon
3082
Intercorp Financial Services
IFS
$6.63B
$236K ﹤0.01%
+10,052
New +$277K
FMTX
3083
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$236K ﹤0.01%
+34,142
New +$240K
WYNN icon
3084
Wynn Resorts
WYNN
$10.1B
$235K ﹤0.01%
+4,121
New +$272K
FHB icon
3085
First Hawaiian
FHB
$3.42B
$234K ﹤0.01%
+10,287
New +$258K
HOLX
3086
DELISTED
Hologic
HOLX
$233K ﹤0.01%
3,360
-277,580
-99% -$20.6M
RVNC
3087
DELISTED
Revance Therapeutics, Inc.
RVNC
$233K ﹤0.01%
16,858
-105,740
-86% -$1.63M
MBTC
3088
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
$233K ﹤0.01%
22,522
CXM icon
3089
Sprinklr
CXM
$1.33B
$232K ﹤0.01%
22,937
-33,777
-60% -$410K
PPTA
3090
Perpetua Resources
PPTA
$2.23B
$232K ﹤0.01%
70,064
-58,509
-46% -$210K
ACNT icon
3091
Ascent Industries
ACNT
$137M
$231K ﹤0.01%
16,482
-6,662
-29% -$106K
IEV icon
3092
iShares Europe ETF
IEV
$1.63B
$231K ﹤0.01%
+5,400
New +$252K
IEZ icon
3093
iShares US Oil Equipment & Services ETF
IEZ
$367M
$231K ﹤0.01%
+14,432
New +$272K
PKBK icon
3094
Parke Bancorp
PKBK
$390M
$231K ﹤0.01%
+11,000
New +$258K
CBAN icon
3095
Colony Bankcorp
CBAN
$462M
$230K ﹤0.01%
+15,275
New +$255K
IBTX
3096
DELISTED
Independent Bank Group, Inc.
IBTX
$230K ﹤0.01%
+3,380
New +$236K
IHE icon
3097
iShares US Pharmaceuticals ETF
IHE
$1.47B
$229K ﹤0.01%
3,588
-366
-9% -$23.2K
PETWW
3098
CALL
DELISTED
Wag! Group Co Warrant
PETWW
$229K ﹤0.01%
29,388
AMBR
3099
Amber International Holding Ltd
AMBR
$138M
$229K ﹤0.01%
34,421
-35,215
-51% -$291K
GLOP
3100
DELISTED
GASLOG PARTNERS LP
GLOP
$229K ﹤0.01%
41,347
-362,329
-90% -$1.99M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.